Articles

Why the U.S. economy is still strong despite the Fed’s 2022-23 rate hikes

Something surprising happened on the way toward the highest U.S. interest rates in more than a dozen years as the Federal Reserve increased rates in 2022 and 2023: Neither consumers nor businesses buckled under the weight of higher borrowing costs.

Carvana slammed by Hindenburg, but its stock continues its meteoric rise

Carvana Co. sidesteps a scathing short-seller report out on Thursday that called the company’s turnaround a “mirage.”

Will crypto continue to rally? Trump’s first 100 days will be the key.

For crypto’s bull run to continue, digital assets enthusiasts hope for a more friendly regulatory environment under the second Donald Trump administration and a favorable macroeconomic setup to support gains for risk assets.

Do stock holdings reflect individual risk preferences or the growing use of target-date funds?

I suspected most financial assets were in 401(k) plans and most 401(k) holdings were directed by target-date funds, but the data told a somewhat different story.

What stocks’ worst stumble since 1952 in the final days of 2024 may mean for 2025

Here’s how the S&P 500 has historically performed annually after stumbling in the final days of a year, according to Bespoke Investment Group.

Mortgage rates inch up to start the year at a near six-month high. Will the housing market become more affordable in 2025?

The 30-year mortgage rate averaged at 6.91%, Freddie Mac said in its latest weekly survey on Thursday.

Google’s antitrust woes spark analyst downgrade of Alphabet’s stock

JMP Securities cited “the risk of antitrust penalties that could significantly impact Google’s U.S. distribution of search and search revenue.”

Widen the aperture for space stocks to watch in 2025 — the story doesn’t begin and end with SpaceX and Boeing

After a big year for SpaceX — and one of misfortune for Boeing — here’s what to expect in the new year.

Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals

News is a setback for the clinical-stage biotech and a drug that proved successful in earlier trials

This factor makes 11 stocks look like better bargains even after they soared in 2024

Some stocks’ price-to-earnings valuations declined even as they outpaced the S&P 500’s big gain.

Tesla’s stock slides after fourth-quarter and full-year sales fall short of estimates

Tesla Inc. said Thursday it delivered more than 495,000 vehicles in the fourth quarter and 1.704 million for all of 2024, falling slightly short of analyst estimates and lagging the year-earlier total.

What to expect in 2025 if economist forecasts are as bad as usual

Nobody has a crystal ball, and that’s demonstrated every year when Wall Street’s professionals hazard a guess on what to expect for the following year.
1 217 218 219 220 221 2,020